Loading…
cbdMD, Inc. is projected to decline to $0.7864 by 2027, a -4% move from its current price of $0.819. YCBD is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $0.7929 | $0.8192 | $0.8464 | +0.02% |
| Jul 13 | $0.7824 | $0.8194 | $0.8581 | +0.04% |
| Jul 14 | $0.7745 | $0.8195 | $0.8672 | +0.06% |
| Jul 15 | $0.7679 | $0.8197 | $0.875 | +0.09% |
| Jul 16 | $0.7621 | $0.8199 | $0.882 | +0.11% |
| Jul 17 | $0.757 | $0.8201 | $0.8883 | +0.13% |
| Jul 18 | $0.7523 | $0.8202 | $0.8942 | +0.15% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.7523 | $0.8202 | $0.8942 | +0.15% |
| Week 2 | $0.727 | $0.8215 | $0.9282 | +0.30% |
| Week 3 | $0.7084 | $0.8227 | $0.9555 | +0.45% |
| Week 4 | $0.6932 | $0.8239 | $0.9793 | +0.60% |
| Week 5 | $0.6802 | $0.8252 | $1.00 | +0.75% |
| Week 6 | $0.6688 | $0.8264 | $1.02 | +0.90% |
| Week 7 | $0.6585 | $0.8276 | $1.04 | +1.05% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
cbdMD, Inc. produces and distributes cannabidiol (CBD) products in the United States and internationally. The company owns and operates consumer hemp-based CBD brands, with its cbdMD brand offering oils, gummies, capsules, soft-gels, topicals, functional formulations, and hemp-derived compliant Delta-9 THC products.
It also provides products for dogs and cats under the Paw CBD brand name; non-cannabinoid functional ingredients under the ATRx brand; and hemp-derived solutions under the Herbal Oasis brand. It serves retailers and health and pet channels through the direct-to-consumer channel, e-commerce platforms, online marketplaces, and wholesale distribution.
The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD is based in Charlotte, North Carolina.
cbdMD, Inc. trades as YCBD. The current price is $0.81 and the market cap is $8.5M. It ranks 5176 by market capitalization.
The near-term outlook reflects a neutral stance in 2026, with a min of $0.654, an average of $0.81, and a max of $0.988, and an ROIPct of 0.
Longer-term forecasts show gradual upside from 2030 onward, with 2030 average around $0.8099 and 2031 around $0.912, lifting to 2032 average of $1.08 and 2033 around $1.00. The forecast accelerates further into the late 2030s and into 2040 ($1.43 average) and 2050 ($2.41 average), indicating meaningful appreciation across the horizon.
A major floor 27.6% below — a decisive break under it would weaken the trend.
The nearest floor, 19.3% below — buyers have tended to step in here.
Price is pressing into resistance (0.9% away) — a breakout level to watch.
A major ceiling 23.3% above — clearing it would confirm fresh momentum.
Key YCBD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of YCBD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.7594 | Buy | $0.7633 | Buy |
| MA 10 | $0.723 | Buy | $0.7384 | Buy |
| MA 20 | $0.7039 | Buy | $0.726 | Buy |
| MA 50 | $0.7554 | Buy | $0.7448 | Buy |
| MA 100 | $0.7728 | Buy | $0.7867 | Buy |
| MA 200 | $0.8733 | Sell | $1.01 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 60.14 | Neutral |
| Stoch RSI (14) | 82.08 | Sell |
| CCI (20) | 188.77 | Buy |
| Williams %R (14) | -15.44 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | 18.17 | Buy |
| Bollinger %B (20,2) | 1.03 | Sell |
| Stochastic %K (14) | 84.56 | Sell |
| TRIX (15) | -0.26 | Sell |
| Awesome (5,34) | 0.04 | Buy |
| Ultimate (7,14,28) | 73.48 | Sell |
| Momentum (10) | 0.08 | Buy |
| Aroon Osc (25) | 40.00 | Buy |
| Hull MA (9) | 0.80 | Buy |
| ADX (14) | 14.98 | Neutral |
| ATR (14) | 0.02 | Info |
The 30-day technical picture shows bullish sentiment overall. RSI14 is 60, while the SMA50 is $0.7579 and the SMA200 is $0.8728. The stock has established a near-term support at $0.661 and a resistance at $0.826.
The 30-day price range spans from a low of $0.6503 to a high of $1.01, highlighting a relatively tight range around the current price. Annualized volatility is 60%, underscoring notable price variability within the month.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.654 | $0.819 | $0.9995 | 0% | Neutral | |
| $0.6147 | $0.7864 | $1.07 | -4% | Neutral | |
| $0.5498 | $0.7278 | $1.03 | -11% | Neutral | |
| $0.5768 | $0.7855 | $1.15 | -4% | Neutral | |
| $0.6056 | $0.8458 | $1.28 | +3% | Neutral | |
| $0.6632 | $0.9479 | $1.47 | +16% | Neutral | |
| $0.7665 | $1.12 | $1.77 | +37% | Bullish | |
| $0.7008 | $1.04 | $1.69 | +28% | Bullish | |
| $0.6371 | $0.9682 | $1.59 | +18% | Neutral | |
| $0.6841 | $1.06 | $1.77 | +29% | Bullish | |
| $0.8868 | $1.50 | $2.68 | +83% | Bullish | |
| $1.31 | $2.57 | $5.10 | +214% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.654 | $0.819 | $0.9776 | +0.00% |
| August 2026 | $0.7052 | $0.8369 | $1.02 | +2.18% |
| September 2026 | $0.6978 | $0.8351 | $1.03 | -0.21% |
| October 2026 | $0.6569 | $0.7919 | $0.9918 | -5.18% |
| November 2026 | $0.6385 | $0.7745 | $0.9789 | -2.20% |
| December 2026 | $0.6428 | $0.784 | $0.9995 | +1.24% |
Click any year to see its month-by-month YCBD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, YCBD is projected to trade between $0.654 and $0.9995, averaging $0.819 — a potential gain of 0% from today's $0.819. A consolidation phase looks the most probable path here.
cbdMD, Inc.'s 2027 outlook centres on $0.7864, within a $0.6147 to $1.07 range. That is -4% versus the projected 2026 average. That marks a -4% change versus current levels. Price action looks broadly range-bound.
By 2028, YCBD could reach as high as $1.03, with a base case around $0.7278 and support toward $0.5498 — roughly -11% from $0.819. A consolidation phase looks the most probable path here.
Expect YCBD to range from $0.5768 to $1.15 through 2029. The $0.7855 average target implies a -4% move from current prices. That is up +8% on the projected 2028 average. Price action looks broadly range-bound.
The YCBD price prediction for 2030 points to an average of $0.8458 (low $0.6056, high $1.28) — a potential gain of +3% on today's $0.819. A consolidation phase looks the most probable path here.
In 2031, YCBD is projected to trade between $0.6632 and $1.47, averaging $0.9479 — a potential gain of +16% from today's $0.819. That is up +12% on the projected 2030 average. Price action looks broadly range-bound.
cbdMD, Inc.'s 2032 outlook centres on $1.12, within a $0.7665 to $1.77 range. That is up +18% on the projected 2031 average. That marks a +37% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, YCBD could reach as high as $1.69, with a base case around $1.04 and support toward $0.7008 — roughly +28% from $0.819. Momentum favours further upside here.
Expect YCBD to range from $0.6371 to $1.59 through 2034. The $0.9682 average target implies a +18% move from current prices. That is -7% versus the projected 2033 average. A consolidation phase looks the most probable path here.
The YCBD price prediction for 2035 points to an average of $1.06 (low $0.6841, high $1.77) — a potential gain of +29% on today's $0.819. Momentum favours further upside here.
In 2040, YCBD is projected to trade between $0.8868 and $2.68, averaging $1.50 — a potential gain of +83% from today's $0.819. That is up +41% on the projected 2035 average. Buyers look set to stay in control over this stretch.
cbdMD, Inc.'s 2050 outlook centres on $2.57, within a $1.31 to $5.10 range. That is up +72% on the projected 2040 average. That marks a +214% change versus current levels. Momentum favours further upside here.
Investing $1,000 in YCBD today (≈ 1,221.001221 YCBD) could be worth
$3,139.99
+$2,139.99 (+214%) by 2050 · US Dollar
Based on the average projected YCBD price of $2.57 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in YCBDwould be worth at today's price.
$1,000 invested in YCBD on Jul 10, 2025 (≈ 1,075.268809 YCBD) would be worth
$880.65
-$119.35 (-11.9%) today · 0.88× · US Dollar
Based on a YCBD entry price of $0.93 vs. today's $0.819.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.685 | $1,195.62 | +19.6% |
| 1 month ago | $0.692 | $1,183.53 | +18.4% |
| 3 months ago | $0.68 | $1,204.41 | +20.4% |
| 6 months ago | $1.16 | $706.03 | -29.4% |
| 1 year ago | $0.93 | $880.65 | -11.9% |
| All time (5.0y) ago | $1,004.4 | $0.82 | -99.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our YCBD forecast.
Our base-case forecast reaches $1.60 around 2050.
Implied market cap at $1.60: $16.8M
Over the multi-year horizon, the forecast paints a cautious-to-bullish path. The 2026 min/max are $0.654 and $0.988 respectively, with an average price of $0.81 and an ROI of 0, signaling a stable near-term outlook. By 2032 the average rises to $1.08 with a max of $1.72 and a notable shift to bullish sentiment, following a 2031 avg of $0.912 and ROI of 12.6.
The trajectory continues higher in 2033 ($1.00 avg, max $1.63) and 2035 ($1.01 avg, max $1.71), with bullish momentum taking hold by 2040 ($1.43 avg, max $2.58) and culminating in 2050 ($2.41 avg, max $4.81).
Across these years, the model flags sentiment as Neutral through 2030, then shifts to Bullish from 2032 onward, aligning with rising average prices. These are projection metrics and not guarantees, and actual results depend on factors affecting the CBD market, regulatory developments, and broader market dynamics.
Tap a question to reveal the answer.
The 2030 forecast lists a min of $0.5773, an avg of $0.8099, and a max of $1.23, with an ROI of 0 and Neutral sentiment.
Long-term forecasts show Neutral sentiment through 2030, then rising to Bullish later in the horizon, with significant upside potential by 2040 and 2050. However, these are estimates, not guarantees, and depend on market and regulatory factors.
Yes—the 2040 max forecast is $2.58, which is above $2.
The 30-day range is from $0.6503 to $1.01.
The current price is $0.81 and the market cap is $8.5M.
cbdMD, Inc. Community Discussion
0Share your cbdMD, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.